BIOA B — BioArctic AB Income Statement
0.000.00%
Last trade - 00:00- SEK16.72bn
- SEK16.26bn
- SEK257.35m
Annual income statement for BioArctic AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 62.3 | 23.1 | 228 | 616 | 257 |
| Cost of Revenue | |||||
| Gross Profit | 39 | -1.71 | 195 | 565 | 230 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 147 | 163 | 246 | 363 | 486 |
| Operating Profit | -85 | -140 | -17.3 | 253 | -229 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -86.7 | -141 | -11.2 | 276 | -190 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -68.5 | -120 | -11.2 | 229 | -177 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -68.5 | -120 | -11.2 | 229 | -177 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -68.5 | -120 | -11.2 | 229 | -177 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.778 | -1.36 | -0.13 | 2.59 | -2 |
| Dividends per Share |